— Know what they know.
Not Investment Advice

SLNX OTC

Solanbridge Group, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +400.0% 1Y: +400.0% 3Y: -50.0% 5Y: -66.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $476000 mcap · 3.27B float · 0.038% daily turnover

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +0.0% ▲
Operating Income
-$60 -263.6% ▼
Net Income
-$68 -95.5% ▼
EPS (Diluted)
$0.00 +0.0% ▲
EBITDA
-$68K -372952.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$0$0
Gross Profit$0$0$0$0$0
Gross Margin—————
R&D Expenses$0$0$0$0$0
SG&A Expenses$7K$7K$7K$16$60
Operating Expenses$7K$7K$7K$25$68
Operating Income-$7K-$7K-$7K-$16-$60
Operating Margin—————
Interest Expense$60$11$11$0$0
Income Before Tax-$7K-$7K-$7K-$35-$68K
Tax Expense$0$0$0$0$0
Net Income-$7K-$7K-$7K-$35-$68
Net Margin—————
EPS (Diluted)$-0.00$0.00$0.00$0.00$0.00
EBITDA-$7K-$7K-$7K-$18-$68K
Shares Outstanding2.61B2.61B2.61B3M5M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms